These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 22392136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis.
    Shakya N, Sane SA, Vishwakarma P, Gupta S.
    Exp Parasitol; 2012 Jul; 131(3):377-82. PubMed ID: 22626518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.
    Shakya N, Sane SA, Gupta S.
    Parasitol Res; 2011 Apr; 108(4):793-800. PubMed ID: 21212980
    [Abstract] [Full Text] [Related]

  • 7. Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis.
    Sane SA, Shakya N, Gupta S.
    Exp Parasitol; 2011 Feb; 127(2):376-81. PubMed ID: 20846525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasis.
    Shivahare R, Ali W, Vishwakarma P, Natu SM, Puri SK, Gupta S.
    Acta Trop; 2015 Oct; 150():35-41. PubMed ID: 26119043
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor receptor contributes to antileishmanial function of miltefosine.
    Gangalum PR, de Castro W, Vieira LQ, Dey R, Rivas L, Singh S, Majumdar S, Saha B.
    J Immunol; 2015 Jun 15; 194(12):5961-7. PubMed ID: 25980013
    [Abstract] [Full Text] [Related]

  • 11. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
    Tripathi CD, Kushawaha PK, Sangwan RS, Mandal C, Misra-Bhattacharya S, Dube A.
    Phytomedicine; 2017 Jan 15; 24():87-95. PubMed ID: 28160866
    [Abstract] [Full Text] [Related]

  • 12. CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis.
    Gupta S, Sane SA, Shakya N, Vishwakarma P, Haq W.
    Antimicrob Agents Chemother; 2011 Jul 15; 55(7):3461-4. PubMed ID: 21537026
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P, Yardley V, Croft SL.
    Antimicrob Agents Chemother; 2001 Jun 15; 45(6):1872-5. PubMed ID: 11353640
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.